https://www.elesta-echolaser.com/wp-content/uploads/2022/03/Aramed-Soractelite_canadian-Specialist-Hospital.mp4 Aramed brings our Elesta Echolaser treatment to the... Leggi tutto
Korian Group: Echolaser, laser-ultrasound technology for prostate and thyroid treatment
Ruetir February 22, 2022 The innovative micro-invasive EchoLaser system will allow the facilities of the Korian group to provide an even excellent service to their patients suffering from prostate and thyroid pathologies. The scope is to reduce the time of the... Leggi tutto
Delphi Consensus – EchoLaser SoracteLite
January 14, 2022 Consequent to the rapid increase of the hospitals where EchoLaser SoracteLite is used to treat BPH, Elesta has initiated a national project for the elaboration of a Delphi Consensus (which will be submitted for publication), aiming at standardizing... Leggi tutto
New CPT Code Has Been Approved by the AMA for Transperineal Laser Ablation of the Prostate
November 1, 2021 Effective from July 1, 2022, the specific CPT code will allow EchoLaser SoracteLite treatment to spread quickly, with benefits for hospitals, payers and most of all patients. Click here to get more details. Leggi tutto
20 Italian IEA Congress
September 6-8, 2021, Bari – Italy The 20th edition of the Italian Endourology Association will be held on September 6-8 at The Nicolaus Hotel of Bari, during the event SoracteLite procedure for the treatment of benign prostatic hyperplasia will be presented by... Leggi tutto
NASOIE first webinar on thyroid laser ablation
Webinar July 24, 2021 The North American Society of Interventional Endocrinologists will present its first webinar on laser ablation for the management of thyroid lesions. Save your seat by clicking here or by scanning the QR code reported on the... Leggi tutto
